Loading...
•
Sep 30, 2022
Hims & Hers Q3 2022 Earnings Report
Reported financial results for the third quarter ended September 30, 2022.
Key Takeaways
Hims & Hers Health, Inc. reported exceptional performance in Q3 2022, with a 95% increase in revenue year-over-year. Net new subscriptions reached an all-time high, and the company raised its full-year 2022 revenue and Adjusted EBITDA guidance. The company expects Adjusted EBITDA profitability beginning in Q4 2022.
Revenue was $144.8 million, up 95% year-over-year.
Net new subscriptions reached an all-time high of over 170,000, ending Q3 2022 with 991,000 subscriptions, up 80% year-over-year.
Gross margin was 79% compared to 74% for the third quarter 2021.
The company raises full year 2022 revenue guidance to the range of $519 million to $522 million and Adjusted EBITDA guidance to the range of $(20) million to $(18) million
Hims & Hers
Hims & Hers
Hims & Hers Revenue by Segment
Revenue by Segment
Online Revenue
CapyFin.comWholesale Revenue
CapyFin.com Forward Guidance
For the fourth quarter 2022, the company expects revenue to be in the range of $159 million to $162 million and Adjusted EBITDA to be in the range of $0 million to $2 million. For the full year 2022, the company expects revenue to be in the range of $519 million to $522 million and Adjusted EBITDA to be in the range of $(20) million to $(18) million.
Positive Outlook
- Revenue to be in the range of $159 million to $162 million for Q4 2022.
- Adjusted EBITDA to be in the range of $0 million to $2 million for Q4 2022.
- Revenue to be in the range of $519 million to $522 million for the full year 2022.
- Adjusted EBITDA to be in the range of $(20) million to $(18) million for the full year 2022.
- Adjusted EBITDA margin in the range of 0% to 1% for Q4 2022.
Challenges Ahead
- Adjusted EBITDA to be in the range of $(20) million to $(18) million for the full year 2022.
- Adjusted EBITDA margin in the range of (4)% to (3)% for the full year 2022.
- The guidance constitutes forward-looking statements and actual results may differ materially.
- The company has not reconciled forward-looking Adjusted EBITDA to its most directly comparable U.S. GAAP measure, net loss.
- The ultimate outcome of certain components of such reconciliations, including market-related assumptions that are not within the company's control, or others that may arise, cannot be predicted with reasonable certainty without unreasonable effort.
Revenue & Expenses
Visualization of income flow from segment revenue to net income